Lonsurf® (Trifluridine/Tipiracil) Plus Chemotherapy in Metastatic Colorectal Cancer Prospective Study in Taiwan

This study is looking at how well the drug Lonsurf (trifluridine/tipiracil) combined with chemotherapy works in patients in Taiwan with colorectal cancer that has spread and has already been treated with multiple standard therapies. **You may be eligible if...** - You have metastatic colorectal cancer confirmed by biopsy - You have already been treated with standard chemotherapy regimens including fluorouracil, oxaliplatin, irinotecan, and anti-VEGF therapy - If your tumor is RAS wild-type, you have also received anti-EGFR therapy - You have at least one measurable tumor lesion - You are in adequate physical condition to receive further chemotherapy **You may NOT be eligible if...** - You have not received the required prior therapies - You have serious organ dysfunction that would make chemotherapy unsafe - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.